Shu-Pang Huang

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

Gregory T. Everson, Karen Sims, M. Rodríguez‐Torres et al. · Gastroenterology · 2013 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder

Vladimir Coric, Howard Feldman, Dan A. Oren et al. · Depression and Anxiety · 2010 · 175 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

Anna S. Lok, David Gardiner, Christophe Hézode et al. · Journal of Hepatology · 2013 · 139 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

C Pasquinelli, Fiona McPhee, Timothy Eley et al. · Antimicrobial Agents and Chemotherapy · 2012 · 51 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17